Special Issue “Advances in Molecular Pathogenesis and Targeted Therapies for Myeloid Neoplasms”-Reference-Cited by-同舟云学术

Special Issue “Advances in Molecular Pathogenesis and Targeted Therapies for Myeloid Neoplasms”

Published:2024-02-08 Issue:4 Volume:25 Page:2056
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Kok Chung Hoow¹²³⁴^ORCID,Yeung David T.¹²⁵,Hiwase Devendra K.¹²⁵

Affiliation:

1. Precision Cancer Medicine Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide 5000, Australia

2. Adelaide Medical School, University of Adelaide, Adelaide 5000, Australia

3. Department of Genetics and Molecular Pathology, Centre for Cancer Biology, SA Pathology, Adelaide 5000, Australia

4. Clinical and Health Sciences, University of South Australia, Adelaide 5000, Australia

5. Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide 5000, Australia

Abstract

Myeloid neoplasms (MNs) constitute a diverse group of haematological malignancies that includes myelodysplastic neoplasms (MDS), myeloproliferative neoplasms (MPN), MDS/MPN overlap syndrome, and acute myeloid leukaemia (AML) [...]

Publisher

MDPI AG

Link

https://www.mdpi.com/1422-0067/25/4/2056/pdf

Reference21 articles.

2. Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence;Genovese;N. Engl. J. Med.,2014

3. Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes;Jaiswal;N. Engl. J. Med.,2014

4. Therapy-related myeloid neoplasms: When genetics and environment collide;McNerney;Nat. Rev. Cancer,2017

5. A senescence stress secretome is a hallmark of therapy-related myeloid neoplasm stromal tissue occurring soon after cytotoxic exposure;Kutyna;Leukemia,2022